本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Viridian Therapeutics, Inc.

19.56
0.0000
成交量:30.13萬
成交額:588.89萬
市值:15.97億
市盈率:-5.49
高:19.97
開:19.82
低:19.33
收:19.56
52周最高:27.20
52周最低:9.90
股本:8,166.80萬
流通股本:6,694.34萬
量比:0.44
換手率:0.45%
股息:- -
股息率:- -
每股收益(TTM):-3.5633
每股收益(LYR):-3.0722
淨資產收益率:-65.88%
總資產收益率:-39.77%
市淨率:4.90
市盈率(LYR):-6.37

資料載入中...

2024/11/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/10/18

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/09/17

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/12

重要事件披露

Form 8-K - Current report
2024/09/10

重要事件披露

Form 8-K - Current report
2024/08/12

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/08/08

重要事件披露

Form 8-K - Current report
2024/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/15

重要事件披露

Form 8-K - Current report
2024/06/20

重要事件披露

Form 8-K - Current report
2024/05/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/08

重要事件披露

Form 8-K - Current report
2024/04/16

重要事件披露

Form 8-K - Current report
2024/04/01

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/28

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]